Published on in Vol 5, No 1 (2021): January

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/20636, first published .
Cancer Patients’ Perceived Value of a Smartphone App to Enhance the Safety of Home-Based Chemotherapy:  Feasibility Study

Cancer Patients’ Perceived Value of a Smartphone App to Enhance the Safety of Home-Based Chemotherapy: Feasibility Study

Cancer Patients’ Perceived Value of a Smartphone App to Enhance the Safety of Home-Based Chemotherapy: Feasibility Study

Journals

  1. Villegas F, Martínez-Borba V, Suso-Ribera C, Castilla D, Zaragoza I, García-Palacios A, Ferrer C. Characterizing Breakthrough Cancer Pain Using Ecological Momentary Assessment with a Smartphone App: Feasibility and Clinical Findings. International Journal of Environmental Research and Public Health 2021;18(11):5991 View
  2. Agafonova Y, Fedyaev D, Snegovoy A, Omelyanovskiy V. Improving the efficiency of the medicine provision system for patients with malignant neoplasms. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology 2022;15(2):209 View
  3. Jang H, Kim S, Kim D, Park M, Rhue S, Lee C, Kim S, Kang B, Lee H. “It's a part of the patient”: The experiences of patients with cancer undergoing home-based chemotherapy from patients' and nurses' perspectives. Asia-Pacific Journal of Oncology Nursing 2022;9(8):100072 View
  4. Tudor A, Nichifor E, Litră A, Chițu I, Brătucu T, Brătucu G. Challenges in the Adoption of eHealth and mHealth for Adult Mental Health Management—Evidence from Romania. International Journal of Environmental Research and Public Health 2022;19(15):9172 View
  5. Parodi A, Buzaeva P, Nigovora D, Baldin A, Kostyushev D, Chulanov V, Savvateeva L, Zamyatnin A. Nanomedicine for increasing the oral bioavailability of cancer treatments. Journal of Nanobiotechnology 2021;19(1) View
  6. Dowling M, Kelly M. Acalabrutinib in the management of chronic lymphocytic leukaemia. Journal of Prescribing Practice 2022;4(2):72 View
  7. Ardito V, Golubev G, Ciani O, Tarricone R. Evaluating Barriers and Facilitators to the Uptake of mHealth Apps in Cancer Care Using the Consolidated Framework for Implementation Research: Scoping Literature Review. JMIR Cancer 2023;9:e42092 View
  8. Vaffis S, Whaley S, Axon D, Hall-Lipsy E, Hincapie A, Slack M, Warholak T. Features of Cancer mHealth Apps and Evidence for Patient Preferences: Scoping Literature Review. JMIR Cancer 2023;9:e37330 View
  9. Hægermark E, Kongshaug N, Raj S, Hofsli E, Faxvaag A. Design, Development, and Evaluation of an mHealth App for Reporting of Side Effects During Cytostatic Treatment: Usability Test and Interview Study. JMIR Formative Research 2023;7:e47374 View
  10. Mueller E, Cochrane A, Carroll A. Perceptions of chemotherapy calendar creation among US pediatric oncologists. Pediatric Blood & Cancer 2023;70(12) View
  11. Sprave T, Pfaffenlehner M, Stoian R, Christofi E, Rühle A, Zöller D, Fabian A, Fahrner H, Binder H, Schäfer H, Gkika E, Grosu A, Heinemann F, Nicolay N. App-Controlled Treatment Monitoring and Support for Patients With Head and Neck Cancer Undergoing Radiotherapy: Results From a Prospective Randomized Controlled Trial. Journal of Medical Internet Research 2023;25:e46189 View
  12. Rosenberg T, Kirkegaard J, Tveden M, Hyldig N, Dieperink K, Steffensen N, Ulriksen S, Lund T. Making decisions for follow-up chemotherapy based on digital patient reported outcomes data in patients with multiple myeloma and other M protein diseases – A mixed method study. European Journal of Oncology Nursing 2024;68:102455 View